Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1Phase 2/3 1

Status

Completed 3Unknown 2Recruiting 2

Sponsor Class

OTHER 7INDUSTRY 1

Study Type

Observational 4Interventional 3

Sponsor

Cancer Type

Myeloid 6

Conditions

Breast Neoplasms 9481Neoplasms 6589Prostatic Neoplasms 4399Colorectal Neoplasms 3978Lung Neoplasms 3644Carcinoma, Non-Small-Cell Lung 3585Pancreatic Neoplasms 2479Carcinoma, Hepatocellular 2413Leukemia, Myeloid, Acute 2265Multiple Myeloma 2121Stomach Neoplasms 2109Neoplasm Metastasis 1911Head and Neck Neoplasms 1870Ovarian Neoplasms 1773Precursor Cell Lymphoblastic Leukemia-Lymphoma 1734Lymphoma 1730Brain Neoplasms 1702Rectal Neoplasms 1676Melanoma 1656Colonic Neoplasms 1629Leukemia 1500Uterine Cervical Neoplasms 1499Recurrence 1486Esophageal Neoplasms 1312Glioblastoma 1308Lymphoma, Non-Hodgkin 1205Leukemia, Lymphocytic, Chronic, B-Cell 1120Squamous Cell Carcinoma of Head and Neck 1109Urinary Bladder Neoplasms 1078Lymphoma, Follicular 1067

Interventions

Imatinib Mesylate 1Cladribine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
OTHER × Mast Cell Activation Disorders × Clear all
NCT06186856 2026-04-22

DATAMAST

Imagine Institute

Recruiting
13,000 enrolled
Myeloid

Mast Cell Activation Disorders, Mastocytosis

NCT06466889 2024-06-26

MastoR

University of Zurich

Recruiting
400 enrolled
Myeloid

Mast Cell Activation Disorders, Mastocytosis

NCT04978740 2022-12-01

Ocular and Palpebral Manifestations of Mastocytosis (MOOMA)

Poitiers University Hospital

Phase NA Completed
21 enrolled

Mast Cell Activation Syndrome, Mast Cell Activation Disorders, Urticaria Pigmentosa

NCT04615663 2020-11-04

MCD&BuDi

University Hospital, Toulouse

Unknown
200 enrolled
Myeloid

Mast Cell Activation Disorders, Mastocytosis

NCT00336076 2016-11-07

Molecular Mechanisms and Diagnosis of Mastocytosis

University of Michigan

Completed
136 enrolled
Myeloid

Mast Cell Activation Disorders, Anaphylaxis, Mastocytosis, Piebaldism

NCT01297777 2016-08-29

Imatinib in KIT-negative Systemic Mastocytosis

Hospital Virgen de la Salud

Phase 4 Completed
10 enrolled
Myeloid

Mast Cell Activation Disorders, Mastocytosis, Mastocytosis, Systemic

NCT01602939 2016-08-29

Cladribine Plus Pegylated Interpheron Alfa-2a in Systemic Mastocytosis

Hospital Virgen de la Salud

Phase 2/3 Unknown
10 enrolled
Myeloid

Mast Cell Activation Disorders, Mastocytosis, Mastocytosis, Systemic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡